Has Caroline Segura received payments from drug or device companies?

Yes. Drug and device makers reported $3,230 in general payments to Caroline Segura across 205 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Caroline Segura did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Caroline Segura come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Caroline Segura

Family Medicine · Slidell, LANPI 1306871645

Payments from drug & device makers

$3,230in general payments, 2019–2025

Across 205 payments — averaging $15.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$691
Takeda Pharmaceuticals U.S.A., Inc.$432
Amgen$227
Ironwood Pharmaceuticals, Inc$225
QOL Medical, LLC$199
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$190
plus $1K from 20 others

What the payments were for

Food & beverage$3,230100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	46	$691
Takeda Pharmaceuticals U.S.A., Inc.	32	$432
Amgen	26	$227
Ironwood Pharmaceuticals, Inc	17	$225
QOL Medical, LLC	6	$199
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	12	$190
Lilly USA, LLC	8	$143
Redhill Biopharma Inc.	8	$134
Johnson & Johnson	9	$132
Regeneron Healthcare Solutions, Inc.	1	$122
Merck	6	$97
Ardelyx, Inc.	4	$89
Gilead	3	$76
Intra-sana Laboratories	2	$73
Novo Nordisk	4	$71
Braintree Laboratories, Inc.	4	$67
Intercept Pharmaceuticals, Inc.	4	$51
Pfizer	3	$43
Bristol Myers Squibb	2	$42
Daiichi Sankyo Inc.	2	$28
E.r. Squibb & Sons, L.L.C.	1	$23
Evoke Pharma, Inc.	1	$17
Exact Sciences	1	$17
Boehringer Ingelheim	1	$16
Ferring Pharmaceuticals Inc.	1	$13
Medtronic	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Creon$130
DUPIXENT$122
Sucraid$116

How this compares

$3,230 in reported general payments places this provider in the 75th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pantoprazole Sodium	82	$1,209
Esomeprazole Magnesium	17	$568
Doxycycline Hyclate	35	$243
Azithromycin	51	$211
Omeprazole	25	$206
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	14	$155
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	13	$121
Dexamethasone	14	$113
Fluoxetine Hcl	15	$110

Paid to pharmacies, not to this prescriber.

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Most prescribed under Part D

Other family medicine in Slidell